Turtle Creek Wealth Advisors LLC Purchases 52 Shares of Danaher Co. (NYSE:DHR)

Turtle Creek Wealth Advisors LLC grew its position in shares of Danaher Co. (NYSE:DHR) by 6.4% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 865 shares of the conglomerate’s stock after buying an additional 52 shares during the quarter. Turtle Creek Wealth Advisors LLC’s holdings in Danaher were worth $240,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. Benjamin Edwards Inc. increased its holdings in Danaher by 1.8% during the 2nd quarter. Benjamin Edwards Inc. now owns 2,153 shares of the conglomerate’s stock valued at $538,000 after purchasing an additional 38 shares in the last quarter. Wedge Capital Management L L P NC increased its stake in shares of Danaher by 3.2% in the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock valued at $342,000 after buying an additional 38 shares in the last quarter. Patrick M Sweeney & Associates Inc. raised its holdings in shares of Danaher by 3.4% in the second quarter. Patrick M Sweeney & Associates Inc. now owns 1,230 shares of the conglomerate’s stock valued at $307,000 after buying an additional 40 shares during the last quarter. Trust Co of Kansas lifted its position in Danaher by 4.1% during the 2nd quarter. Trust Co of Kansas now owns 1,022 shares of the conglomerate’s stock worth $255,000 after buying an additional 40 shares in the last quarter. Finally, Abacus Planning Group Inc. grew its holdings in Danaher by 0.7% during the 2nd quarter. Abacus Planning Group Inc. now owns 5,439 shares of the conglomerate’s stock worth $1,359,000 after acquiring an additional 40 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. This represents a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Down 3.7 %

Shares of Danaher stock traded down $8.88 during trading hours on Friday, reaching $230.50. 5,435,775 shares of the company’s stock were exchanged, compared to its average volume of 2,760,084. The stock has a market cap of $166.49 billion, a P/E ratio of 43.99, a P/E/G ratio of 4.44 and a beta of 0.85. The company has a 50 day moving average of $262.20 and a two-hundred day moving average of $260.38. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a fifty-two week low of $206.30 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same period last year, the company earned $2.02 earnings per share. The business’s revenue was up 3.1% compared to the same quarter last year. On average, sell-side analysts forecast that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.47%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

Wall Street Analyst Weigh In

DHR has been the subject of a number of research analyst reports. Raymond James dropped their target price on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. StockNews.com upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research report on Wednesday, November 6th. Wells Fargo & Company assumed coverage on Danaher in a research report on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 price objective on the stock. Robert W. Baird dropped their target price on Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Finally, Royal Bank of Canada decreased their price target on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.